🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

MOBility Disorders Assessment in Patients With Mild COGnitive Disorders

Recruitingn/aAges 65 Years - anyAllUniversity Hospital, Lille
NCT05273125 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Mild cognitive impairment (MCI) is defined by lower performance in one or more cognitive domains with preservation of independence in functional abilities. Sixteen percent of community-dwelling older people (over 65 years) live with MCI. They are both cognitively and physically vulnerable. From a cognitive perspective, they are susceptible to converting to the dementia stage at an annual rate of 10%. From a physical perspective, the proportion of slow gait or neurological gait abnormalities can reach 46% in the population with MCI. Falls in turn increase the risk of accelerated cognitive decline and the risk of institutionalization. In the absence of a curative treatment for dementia, it is essential to have an effective and personalized prevention strategy by identifying the predictive factors for falls in this at-risk population with MCI. The research goals of this project are 1) to i

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient being diagnosed with MCI, according to the 2011 criteria * Able to walk 4 meters with or without technical assistance * Comprehension of French language allowing the realization of the neuropsychological assessment Exclusion Criteria: * Severe visual or hearing impairment that does not allow the assessment * Severe pathology that makes follow-up impossible * Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security insurance, refusal to sign consent form * Under legal protection (guardianship, curatorship, safeguard of justice)
💊

What it tests

  • Gait disorders and falls risk assessment
📍

Where

2 sites
Les Bateliers Chu Lille
Lille, France
Hop Salengro - Hopital B
Lille, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy